Trial
NCT06842589
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Collaborators
—
Condition
Multi-Drug Resistant Nephrotic Syndrome
Intervention
anti-CD19 CAR-T cells
Why stopped
no participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-16